AXDX - Accelerate Diagnostics, Inc.
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Annual
| Revenue | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 |
| Total Revenue | 4,177 | 246 | 147 | 122 |
| Cost of Revenue | 1,002 | - | - | - |
| Gross Profit | 3,175 | 246 | 147 | 122 |
| Operating Expenses | ||||
| Research Development | 22,301 | 29,564 | 27,142 | 19,526 |
| Selling General and Administrative | 45,058 | 37,183 | 18,554 | 10,695 |
| Non Recurring | - | - | - | - |
| Others | - | - | - | - |
| Total Operating Expenses | 68,361 | 66,747 | 45,696 | 31,109 |
| Operating Income or Loss | -64,184 | -66,501 | -45,549 | -30,987 |
| Income from Continuing Operations | ||||
| Total Other Income/Expenses Net | 649 | 394 | 51 | 54 |
| Earnings Before Interest and Taxes | -64,184 | -66,501 | -45,549 | -30,987 |
| Interest Expense | - | - | -4 | -7 |
| Income Before Tax | -63,535 | -66,107 | -45,498 | -30,933 |
| Income Tax Expense | 493 | 267 | - | - |
| Minority Interest | - | - | - | - |
| Net Income From Continuing Ops | -64,028 | -66,374 | -45,498 | -30,933 |
| Non-recurring Events | ||||
| Discontinued Operations | - | - | - | - |
| Extraordinary Items | - | - | - | - |
| Effect Of Accounting Changes | - | - | - | - |
| Other Items | - | - | - | - |
| Net Income | ||||
| Net Income | -64,028 | -66,374 | -45,498 | -30,933 |
| Preferred Stock And Other Adjustments | - | - | - | - |
| Net Income Applicable To Common Shares | -64,028 | -66,374 | -45,498 | -30,933 |
